Please login to the form below

Not currently logged in
Email:
Password:

Icon launches web portal for clinical trial sites

Says iSite will improve study efficiency

Icon iSiteIcon has set up an online portal to improve the efficiency of its trials by giving investigators 24-hour access to study-specific laboratory information.

The contract research organisation's (CRO) new iSite portal allows investigators and other site personnel access to electronic laboratory reports for their active studies at any time.

Tom O'Leary, president of Icon Central Laboratories, said: “We are continuously looking to introduce innovative technology solutions that drive efficiency and improve performance.

“iSite provides investigators a much needed solution for accessing important study-specific information in the most rapid, secure and convenient way possible.”

The new portal includes report management functions and provides investigators with customised views of reports by study, site, subject or visit date.

The firm is already working on the next version of the portal, which it says will provide sites with study-specific performance metrics and additional tools such as customised electronic laboratory manuals.

29th November 2012

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics